-
Pujiang Prostate Cancer Academic Conference | Prof. Fangning Wan: Innovations in Local Therapy, Advances in Systemic Treatment, and Clinical Applications of Cryotherapy for Prostate Cancer
The 2026 Pujiang Prostate Cancer Academic Conference was held in Shanghai from June 26–27, 2026. As treatment strategies for prostate cancer continue to evolve, local therapy has progressed beyond conventional radical surgery toward robot-assisted precision surgery with greater emphasis on functional preservation. Meanwhile, focal therapies such as cryoablation and irreversible electroporation (IRE) have emerged as…
-
Advances in ADC Therapy for Advanced Urothelial Carcinoma | Prof. Kaiwei Yang Reviews the Evolving First- and Later-Line Treatment Landscape
The treatment landscape for advanced urothelial carcinoma (UC) has entered a new era. Antibody-drug conjugates (ADCs) targeting Nectin-4, HER2, and Trop-2 have rapidly transformed clinical practice, while ADCs combined with immune checkpoint inhibitors have become the new standard for first-line treatment. At the 2026 CSCO Annual Meeting, Prof. Kaiwei Yang from the Department of Urology,…
-
Prof. Benkang Shi: Building Academic Synergy Across the Yellow River Region to Advance High-Quality Development of Urology in Shandong
The 3rd Yellow River Urology Congress and the 31st Academic Conference on Urology of the Shandong Medical Association were recently held, bringing together leading urologists from across China to discuss the latest advances in the field, innovations in clinical practice, talent development, and regional collaboration.
-
CUDA 2026 | Prof. Xiaoying Li: From Technological Innovation to MDT Collaboration—Redefining the Landscape of Urologic Oncology
The 2026 Annual Meeting of the Chinese Urological Association (CUDA) was held in Zhengzhou from June 11–14, bringing together leading experts in urology and related disciplines under the theme “Unity, Collaboration, Innovation, and Development.” The meeting focused on advancing high-quality clinical research, technological innovation, multidisciplinary collaboration (MDT), and regional cooperation, while promoting the continued development…
-
BOC 2026 | Prof. Pei Dong: Kidney Cancer Enters the Era of Long-Term Survival, with New Advances in Adjuvant Therapy and Comprehensive Disease Management
In renal cell carcinoma (RCC), continued advances in targeted therapy and immunotherapy have ushered patients with advanced disease into an era of long-term survival and chronic disease management. However, important clinical challenges remain, including optimizing adjuvant treatment for high-risk patients after surgery, selecting effective therapies following immunotherapy resistance, and developing multidisciplinary models for comprehensive care…
-
BOC 2026 | Prof. Wasilijiang-Wahafu: Neoadjuvant Therapy for MIBC Enters a New Era with Precision Stratification and Comprehensive Perioperative Management
In recent years, the perioperative management of muscle-invasive bladder cancer (MIBC) has undergone rapid transformation. The emergence of immunotherapy, antibody-drug conjugates (ADCs), and precision biomarker-driven treatment has fundamentally reshaped the therapeutic landscape.
-
CUDA 2026 | Prof. Nianzeng Xing: Advancing Urology Through Collaboration and Innovation
The 2026 Annual Meeting of the Chinese Urological Association (CUDA) was held in Zhengzhou from June 11–14, 2026. As one of China’s most influential national academic meetings in urology, this year’s conference adopted the theme “Collaboration and Innovation”, bringing together leading domestic and international experts to discuss advances in minimally invasive surgery, robotic technology, precision…
-
CUDA 2026 | Rethinking Tiered Healthcare and Multidisciplinary Care in Urology—An Interview with Prof. Zhisong He
The 2026 Annual Meeting of the Chinese Urological Association (CUDA) was held in Zhengzhou under the theme “Collaboration and Innovation.” The conference focused on key topics including precision diagnosis and treatment of urologic diseases, comprehensive cancer management, and multidisciplinary team (MDT) care, showcasing China’s latest advances in technological innovation and the standardization of clinical practice.
Connecting Medical Expertise through Media